Outlicensing opportunity for Proprietary Compound and Nasal Spray for the Treatment of Obesity

Both ABSOLVE and ABSCENT have been evaluated in the clinic and have been more effective / better tolerated than other obesity therapeutics.
Average weight loss is 10 lbs. during the first month’s use (observed range = 4 lbs. to 15 lbs.) and 2 lbs. to 10 lbs. per month thereafter.
ABSOLVE’s APIs are both components of other diet medicines.
Newer postsOlder posts